MKI67 and neoplasm: Additionally, while sunitinib inhibited primary tumor growth, there was no effect on the cellular proliferation rate, as indicated by the stable percentage of ki-67 positive cells in all treatment arms; this might be again attributed to the limited treatment window but it could also fall in line with the recent observation of prolonged stability of tumor growth rate during sunitinib administration [38].